FotoFinder Expands Global Reach with GHO's Acquisition

GHO Capital Partners LLP has entered into an agreement to acquire a majority stake in FotoFinder Systems, a recognized leader in skin imaging technology. This strategic acquisition supports GHO's investment strategy of targeting high-growth areas within the MedTech sector to improve healthcare outcomes. FotoFinder, which was founded in 1991 and is headquartered in Bavaria, Germany, specializes in dermoscopy, total body mapping, and AI-enabled skin imaging for cancer detection and dermatology. The deal comes on the heels of FotoFinder's recent merger with the US-based DermLite, a leader in analogue dermatoscopes. GHO, supported by Munich-based EMZ Partners in a bilateral transaction, aims to leverage its transatlantic platform and operational expertise to further expand FotoFinder’s global reach and capitalize on synergies with DermLite. The acquisition positions FotoFinder well within a rapidly growing market driven by factors such as rising skin cancer incidence and an ageing population. The transaction aligns with FotoFinder's vision to innovate and expand into adjacent markets such as aesthetics. Jan De Witte, GHO Operating Partner, will become Chairman of FotoFinder's Board, guiding its next growth phase. The transaction is pending regulatory approval and involves the reinvestment of EMZ Partners and management to retain a minority stake.